维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Matsubara LS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Myocardial fibrosis rather than hypertrophy induces diastolic dysfunction in renovascular hypertensive rats显示文摘	Matsubara LS Matsubara BB Okoshi MP et a1	1997	Can J Physiol Phannacol1997，，12：	1
2	Myocardial fibrosis rather than hypertrophy induces diastolic dysfunction in renovascular hypertensive rats显示文摘	Matsubara LS Matsubara BB Okoshi MP	1997	Can J Physiol Phannacol1997，75，12：	1
3	Anti-aldosterone treatment and the prevention myocardial fibrosis in primary and secondary hypertension显示文摘	Brilla Cg Matsubara LS Weber KT	1993	J Mol Cell Cardiol1993，25，7：	1
4	Myocardial remodeling in chronic pressure or volume overload in the rat heart显示文摘	Narikawa S Ferreira AL	2006	Arq Bras Cardio2006，86，：	1
5	Anti - aldosterone treatment and the prevention o{ myocardial fibrosis in primary and secondary hyper - aldosteronism显示文摘	Brilla CG Matsubara LS Weber KT	1993	J Mol Cell Cardiol1993，25，：	1
6	Heart failure with normal ejection fraction 显示文摘	Roscani MG Matsubara LS Matsubara BB	2010	Arq Bras Cardiol2010，94，5：	1
7	Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism显示文摘	Brilla CG Matsubara LS Weber KT	1993	J Mol Cell Cardiol1993，25，：	1
8	Antifibrotic effect of spironolactone in preventingmyocardial fibrosis in systemetic arterial hypertension显示文摘	Brilia CG Matsubara LS Weber KT	1993	Am J Cardiol1993，71，1：	1
9	Myocardial fibrosis rather than hypertrophy induces diastolic dysfunction in renovascular hypertensive rats显示文摘		1997	Can J Physiol Pharmacol1997，75，：	1
10	Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperal-dosteronism显示文摘	Brilla CG Matsubara LS Weber KT	1993	J Mol Cell Cardiol1993，25，：	1
11	Anti -aldosterone treatment and the prevention of myocardial fibrosis in pri- mary and secondary hyperaldosteronism 显示文摘	Brilla CG Matsubara LS Weber KT	1993	J Mol Cell Cardiol1993，25，5：	1
12	Anti-aldostorone trestment and the prevention of myocardial fibrosis in primary and secondary hyperal-dosteonism显示文摘	Matsubara LS Weber KT	1993	J Mol Cell Cardiol1993，25，：	1
13	Protective effects of carvedilol on systemic vascular damage induced by angiotensin II:organ-specific effects independent of antihypertensive effects显示文摘	Vailati Mdo C Rocha NS Matsubara LS	2010	Med Sci Monit2010，16，1：	1
14	Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension显示文摘	Brilla CG Matsubara LS Weber KT	1993	Am J Cardiol1993，71，：	1
15	Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism显示文摘	Brilla CG Matsubara LS Weber KT	1993	J Mol Cell Cardiol1993，25，：	1
16	Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension显示文摘	Brilla CG Matsubara LS Weber KT	1993	Am J Cardiol1993，71，3：	1
17	Effects of losartan on ventricular remodeling in experimental infarction in rats显示文摘	Zornoff LA Matsubara LS Matsubara BB	2000	Arq Bras Cardiol2000，75，6：	1
18	Antifibrotic effects of spironolactone in preventing myocardial fibrosis in stystemic arterial hypertension显示文摘	Brilla CG Matsubara LS Weber KT	1993	Am J Cardiol1993，71，：	1
19	Heart failure with normal ejection fraction 显示文摘	Roscani MG Matsubara LS Matsubara BB	2010	Arq Bras Cardinl2010，94，5：	1
20	Heart failure with normal ejection fraction显示文摘	Roscani MG Matsubara LS Matsubara BB	2010	Arq Bras Cardiol2010，94，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示